NHS Framework Agreement for the Supply of Direct Oral Anticoagulant (DOAC) Medicines for the NHS in England

  • The NHS Commissioning Board (operating under the name of NHS England)

F14: Notice for changes or additional information

Notice reference: 2021/S 000-019266

Published 10 August 2021, 8:51am



Section one: Contracting authority/entity

one.1) Name and addresses

The NHS Commissioning Board (operating under the name of NHS England)

2nd Floor, Rutland House

Runcorn

WA7 2ES

Contact

Gero Lo Manto

Email

gero.lomanto@nhs.net

Country

United Kingdom

NUTS code

UK - United Kingdom

Internet address(es)

Main address

https://www.england.nhs.uk/

Buyer's address

https://www.england.nhs.uk/


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

NHS Framework Agreement for the Supply of Direct Oral Anticoagulant (DOAC) Medicines for the NHS in England

Reference number

C40079

two.1.2) Main CPV code

  • 33600000 - Pharmaceutical products

two.1.3) Type of contract

Supplies

two.1.4) Short description

NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England. Also known as Novel Oral Anticoagulants (NOACs).Period of Framework: 01/11/2021 - 31/04/2024 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 41 months)All documents can be found at https://health.atamis.co.uk/. Atamis Reference Number: C40079


Section six. Complementary information

six.6) Original notice reference

Notice number: 2021/S 000-017393


Section seven. Changes

seven.1.2) Text to be corrected in the original notice

Section number

I.1.8

Place of text to be modified

Contact person

Instead of
Text

Gero Lo Manto

Read
Text

Strategic Category Manager

Section number

I.1.11

Place of text to be modified

Email

Instead of
Text

gero.lomanto@nhs.net

Read
Text

SCMProcurements@nhs.net